Innoviva (INVA) Operating Margin (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 131,294.00 |
| Dec 31, 2025 | -130,609.00 |
| Sep 30, 2025 | -1,654.00 |
| Jun 30, 2025 | 187.00 |
| Mar 31, 2025 | 90,010.00 |
| Dec 31, 2024 | -90,167.00 |
| Sep 30, 2024 | -644.00 |
| Jun 30, 2024 | 111,354.00 |
| Mar 31, 2024 | -62,830.00 |
| Dec 31, 2023 | -55,829.00 |
| Sep 30, 2023 | 111,034.00 |
| Jun 30, 2023 | 44,283.00 |
| Mar 31, 2023 | -44,269.00 |
| Dec 31, 2022 | -98,307.00 |
| Sep 30, 2022 | 49,003.00 |
| Jun 30, 2022 | 22,031.00 |
| Mar 31, 2022 | -9,842.00 |
| Dec 31, 2021 | -70,815.00 |
| Sep 30, 2021 | -816,879.00 |
| Jun 30, 2021 | 877,526.00 |
| Mar 31, 2021 | 77,051.00 |
| Dec 31, 2020 | -137,555.00 |
| Sep 30, 2020 | -81.00 |
| Jun 30, 2020 | -74.00 |
| Mar 31, 2020 | -19.00 |
| Dec 31, 2019 | 448.00 |
| Sep 30, 2019 | -77.00 |
| Jun 30, 2019 | -132.00 |
| Mar 31, 2019 | -216.00 |
| Dec 31, 2018 | 321.00 |
| Sep 30, 2018 | 6.00 |
| Jun 30, 2018 | 1,573.00 |
| Mar 31, 2018 | -1,783.00 |
| Dec 31, 2017 | 1,325.00 |
| Sep 30, 2017 | 60.00 |
| Jun 30, 2017 | 921.00 |
| Mar 31, 2017 | -1,389.00 |
| Dec 31, 2016 | 254.00 |
| Sep 30, 2016 | 412.00 |
| Jun 30, 2016 | 717.00 |
| Mar 31, 2016 | -321.00 |
| Dec 31, 2015 | 1,354.00 |
| Sep 30, 2015 | 1,425.00 |
| Jun 30, 2015 | 3,714.00 |
| Mar 31, 2015 | 902.00 |
| Dec 31, 2014 | 95,694.00 |
| Sep 30, 2014 | 9,345.00 |
| Jun 30, 2014 | 83,896.00 |
| Mar 31, 2014 | -138,403.00 |
| Dec 31, 2013 | 135,358.00 |
| Sep 30, 2013 | -133,532.00 |
| Jun 30, 2013 | 200,371.00 |
| Mar 31, 2013 | -255,937.00 |
| Dec 31, 2012 | 236,605.00 |
| Sep 30, 2012 | 449,556.00 |
| Jun 30, 2012 | -689,612.00 |
| Mar 31, 2012 | 73,186.00 |
| Dec 31, 2011 | -20,938.00 |
| Sep 30, 2011 | -8,380.00 |
| Jun 30, 2011 | -3,381.00 |